Expression and Significance of Glucose Transporter-1, P-glycoprotein, Multidrug Resistance-associated Protein and Glutathione S-transferase-π in Laryngeal Carcinoma

Overview

Journal Oncol Lett

Specialty Oncology

Date 2015 Jan 27

PMID 25621055

Citations 10

Authors

Zhong-Ping Mao

Li-Jun Zhao

Shui-Hong Zhou

Meng-Qin Liu

Wei-Feng Tan

Hong-Tian Yao

Affiliations

Soon will be listed here.

Abstract

Increasing glucose transporter-1 (GLUT-1) activity is one of the most important ways to increase the cellular influx of glucose. We previously demonstrated that increased GLUT-1 expression was an independent predictor of survival in patients with laryngeal carcinoma. Thus, GLUT-1 may present a novel therapeutic target in laryngeal carcinoma. In this study, the expression of GLUT-1, P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1) and glutathione S-transferase-π (GST-π) in laryngeal carcinomas was investigated by immunohistochemistry. Additionally, possible correlations between GLUT-1 and P-gp, MRP1 and GST-π and various clinicopathological parameters were analyzed. In this study, 52.9% (18/34), 58.8% (20/34), 20.6% (7/34) and 58.8% (20/34) of the laryngeal carcinomas were positive for GLUT-1, P-gp, MRP1 and GST-π, respectively. The expression of GLUT-1, P-gp, MRP1 and GST-π was higher in laryngeal carcinoma specimens when compared with laryngeal precancerous lesions (P<0.05). Pearson's correlation analysis showed correlations between GLUT-1 and P-gp (r=0.364; P=0.034), GLUT-1 and MRP1 (r=0.359; P=0.037) and P-gp and GST-π (r=0.426; P=0.012). GLUT-1 expression was found to significantly correlate with tumor-node-metastasis classification (P=0.02) and clinical stage (P=0.037). Furthermore, P-gp was found to significantly correlate with clinical stage (P=0.026). Univariate analysis showed that MRP1 expression was significantly associated with poor survival (c=5.16; P=0.023). Multivariate analysis revealed that lymph node metastasis (P=0.009) and MRP1 overexpression (P=0.023) were significant predictors of poor survival. In the present study, the expression of GLUT-1, P-gp, MRP1 and GST-π in laryngeal carcinomas was investigated, as well as the correlations between these proteins. P-gp was found to significantly correlate with clinical stage, while MRP1 overexpression was significantly associated with poor survival.

Citing Articles

Curcumin Inhibits the PPARδ-p-Akt-GLUT1 Pathway and Ameliorates the Antiproliferative Effects of Doxorubicin in MDA-MB-231 Cells.

Thulasiraman P, Foret M, Pandit R, McAlister K Asian Pac J Cancer Prev. 2024; 25(3):1035-1043.

PMID: 38546086 PMC: 11152400. DOI: 10.31557/APJCP.2024.25.3.1035.

Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and F-FDG uptake in laryngeal and hypopharyngeal carcinomas.

Shen L, Zhou S, Yu Q Transl Cancer Res. 2022; 9(4):2824-2837.

PMID: 35117639 PMC: 8797923. DOI: 10.21037/tcr.2020.02.50.

The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.

Xue F, Xu Y, Song Y, Zhang W, Li R, Zhu X Drug Des Devel Ther. 2019; 13:3919-3928.

PMID: 31819366 PMC: 6873969. DOI: 10.2147/DDDT.S219788.

Construction of a GLUT-1 and HIF-1α gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique.

Lu Z, Yu Q, Zhou S, Fan J, Shen L, Bao Y Cancer Manag Res. 2019; 11:2087-2096.

PMID: 30881132 PMC: 6413817. DOI: 10.2147/CMAR.S183859.

Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro.

Jiang T, Zhou M, Fan J Onco Targets Ther. 2018; 11:7865-7872.

PMID: 30464533 PMC: 6228052. DOI: 10.2147/OTT.S176818.

References

Brophy S, Sheehan K, McNamara D, Deasy J, Bouchier-Hayes D, Kay E . GLUT-1 expression and response to chemoradiotherapy in rectal cancer. Int J Cancer. 2009; 125(12):2778-82. DOI: 10.1002/ijc.24693. View

Wu X, Chen S, Mao J, Ji X, Yao H, Zhou S . Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma. Oncol Lett. 2012; 5(1):261-266. PMC: 3525510. DOI: 10.3892/ol.2012.941. View

Gu J, Yamamoto H, Fukunaga H, Danno K, Takemasa I, Ikeda M . Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci. 2006; 51(12):2198-205. DOI: 10.1007/s10620-006-9428-2. View

Camenzind R, Chip S, Gutmann H, Kapfhammer J, Nitsch C, Bendfeldt K . Preservation of transendothelial glucose transporter 1 and P-glycoprotein transporters in a cortical slice culture model of the blood-brain barrier. Neuroscience. 2010; 170(1):361-71. DOI: 10.1016/j.neuroscience.2010.06.073. View

Shimanishi M, Ogi K, Sogabe Y, Kaneko T, Dehari H, Miyazaki A . Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia. J Oral Pathol Med. 2012; 42(5):382-8. DOI: 10.1111/jop.12028. View

Perez-Sayans M, Supuran C, Pastorekova S, Suarez-Penaranda J, Pilar G, Barros-Angueira F . The role of carbonic anhydrase IX in hypoxia control in OSCC. J Oral Pathol Med. 2012; 42(1):1-8. DOI: 10.1111/j.1600-0714.2012.01144.x. View

Xu Y, Bao Y, Zhou S, Fan J . Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1. Arch Med Res. 2012; 43(5):395-401. DOI: 10.1016/j.arcmed.2012.07.003. View

Chiba I, Ogawa K, Morioka T, Shimoji H, Sunagawa N, Iraha S . Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Oncol Lett. 2012; 2(1):21-28. PMC: 3412522. DOI: 10.3892/ol.2010.199. View

Wang J, Zhang J, Zhang L, Zhao L, Fan S, Yang Z . Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. Oncol Rep. 2011; 26(5):1081-9. DOI: 10.3892/or.2011.1405. View

10.

Yu Z, Peng S, Hong-Ming P, Kai-Feng W . Expression of multi-drug resistance-related genes MDR3 and MRP as prognostic factors in clinical liver cancer patients. Hepatogastroenterology. 2012; 59(117):1556-9. DOI: 10.5754/hge11987. View

11.

Wang B, Zhai H, Chen B, Zhai S, Yang H, Chen X . Clinical relationship between MDR1 gene and gallbladder cancer. Hepatobiliary Pancreat Dis Int. 2004; 3(2):296-9. View

12.

Calatozzolo C, Gelati M, Ciusani E, Sciacca F, Pollo B, Cajola L . Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol. 2005; 74(2):113-21. DOI: 10.1007/s11060-004-6152-7. View

13.

Bourasset F, Cisternino S, Temsamani J, Scherrmann J . Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J Neurochem. 2003; 86(6):1564-7. DOI: 10.1046/j.1471-4159.2003.01990.x. View

14.

Hong B, Lui V, Hashiguchi M, Hui E, Tak-Cheung Chan A . Targeting tumor hypoxia in nasopharyngeal carcinoma. Head Neck. 2011; 35(1):133-45. DOI: 10.1002/hed.21877. View

15.

Zhou S, Fan J, Chen X, Cheng K, Wang S . Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1. Head Neck. 2009; 31(12):1624-33. DOI: 10.1002/hed.21137. View

16.

Cantuaria G, Fagotti A, Ferrandina G, Magalhaes A, Nadji M, Angioli R . GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer. 2001; 92(5):1144-50. DOI: 10.1002/1097-0142(20010901)92:5<1144::aid-cncr1432>3.0.co;2-t. View

17.

Lelong-Rebel I, Brisson C, Fabre M, Bergerat J, Rebel G . Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Anticancer Res. 2008; 28(1A):55-68. View

18.

Min L, Chen Q, He S, Liu S, Ma Y . Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression. Mol Med Rep. 2011; 5(1):228-32. DOI: 10.3892/mmr.2011.604. View